RxDoctor Payments Data

Rochelle Duplechin

Emergency Medicine · Lafayette, LANPI 1972602951

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 54 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Organogenesis Inc. at 41.6% of the total. Among emergency medicine clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,220in general payments, 2019–2025

Across 54 payments — averaging $22.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$508
  • Smith+Nephew$342
  • Tactile Systems Technology Inc$160
  • Convatec Inc.$41
  • Philips North America LLC$39
  • Medline Industries LP$32
  • plus $97 from 4 others

What the payments were for

  • Food & beverage$1,220100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,220 in reported general payments places this provider in the 95th percentile of 881 emergency medicine providers in Louisiana.

See all emergency medicine providers in Louisiana

Medicare billing

Part B allowed, 2024
$94,749
Medicare patients
189
Services billed
1,576

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gentamicin Sulfate15$572
Minocycline Hcl21$292
Doxycycline Hyclate25$260
Nystatin13$242
Mupirocin24$204
Ciprofloxacin Hcl29$129
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim13$55

Paid to pharmacies, not to this prescriber.

Other emergency medicine in Lafayette

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →